{
  "medications": [
    {
      "id": "med-001",
      "name": "Donepezil",
      "genericName": "Donepezil Hydrochloride",
      "brandNames": ["Aricept", "Adlarity"],
      "category": "Cholinesterase Inhibitor",
      "class": "Dementia Treatment",
      "indication": "Alzheimer's Disease (mild to moderate)",
      "dosing": {
        "starting": "5mg once daily at bedtime",
        "maintenance": "10mg once daily after 4-6 weeks",
        "maximum": "23mg once daily for severe AD",
        "renalAdjustment": "No adjustment needed for CrCl >10 mL/min",
        "hepaticAdjustment": "Use with caution in severe hepatic impairment"
      },
      "contraindications": [
        "Known hypersensitivity to donepezil",
        "Severe bradycardia or heart block"
      ],
      "warnings": [
        "May cause bradycardia and heart block",
        "Increased risk of GI bleeding with NSAIDs",
        "May exacerbate asthma or COPD",
        "Can cause muscle cramps and fatigue"
      ],
      "sideEffects": {
        "common": ["Nausea", "Diarrhea", "Insomnia", "Fatigue", "Muscle cramps", "Loss of appetite"],
        "serious": ["Bradycardia", "Heart block", "Seizures", "GI bleeding", "Syncope"]
      },
      "interactions": [
        {
          "drug": "Anticholinergics",
          "severity": "Major",
          "description": "May reduce effectiveness of donepezil"
        },
        {
          "drug": "NSAIDs",
          "severity": "Moderate", 
          "description": "Increased risk of GI bleeding"
        },
        {
          "drug": "Beta-blockers",
          "severity": "Moderate",
          "description": "Additive bradycardia risk"
        }
      ],
      "monitoring": [
        "Heart rate and rhythm",
        "Cognitive function (MMSE, MoCA)",
        "GI symptoms",
        "Sleep patterns",
        "Weight and appetite"
      ],
      "beersCategory": "Not listed",
      "renalDosing": "No adjustment required",
      "geriatricConsiderations": [
        "Start with 5mg and assess tolerance",
        "Monitor for cardiac effects",
        "Evening dosing may help with sleep side effects",
        "Discontinue if no benefit after 6 months"
      ],
      "cost": "$$$ (expensive)",
      "availability": "Tablet, ODT"
    },
    {
      "id": "med-002",
      "name": "Memantine",
      "genericName": "Memantine Hydrochloride",
      "brandNames": ["Namenda", "Namenda XR"],
      "category": "NMDA Receptor Antagonist",
      "class": "Dementia Treatment",
      "indication": "Moderate to severe Alzheimer's Disease",
      "dosing": {
        "starting": "5mg once daily",
        "titration": "Increase by 5mg weekly to target dose",
        "maintenance": "10mg twice daily or 28mg XR once daily",
        "maximum": "20mg daily (10mg BID)",
        "renalAdjustment": "Reduce dose if CrCl <30 mL/min",
        "hepaticAdjustment": "No adjustment for mild-moderate impairment"
      },
      "contraindications": [
        "Known hypersensitivity to memantine",
        "Severe renal impairment (CrCl <5 mL/min)"
      ],
      "warnings": [
        "May worsen seizure disorders",
        "Use caution in alkaline urine conditions",
        "Monitor for increased confusion initially"
      ],
      "sideEffects": {
        "common": ["Dizziness", "Headache", "Confusion", "Constipation", "Hypertension"],
        "serious": ["Falls", "Cerebrovascular events", "Severe confusion"]
      },
      "interactions": [
        {
          "drug": "Carbonic anhydrase inhibitors",
          "severity": "Moderate",
          "description": "May increase memantine levels"
        },
        {
          "drug": "Sodium bicarbonate",
          "severity": "Moderate",
          "description": "Alkalinizes urine, increases drug levels"
        }
      ],
      "monitoring": [
        "Cognitive function",
        "Behavioral symptoms",
        "Renal function",
        "Blood pressure",
        "Falls assessment"
      ],
      "beersCategory": "Not listed",
      "renalDosing": "Reduce dose by 50% if CrCl 5-29 mL/min",
      "geriatricConsiderations": [
        "Slower titration may be needed",
        "Can be combined with cholinesterase inhibitors",
        "Monitor for increased confusion during initiation",
        "May help with agitation and behavioral symptoms"
      ],
      "cost": "$$ (moderate)",
      "availability": "Tablet, Solution, XR"
    },
    {
      "id": "med-003",
      "name": "Haloperidol",
      "genericName": "Haloperidol",
      "brandNames": ["Haldol"],
      "category": "Antipsychotic",
      "class": "Typical Antipsychotic",
      "indication": "Severe agitation in dementia (last resort)",
      "dosing": {
        "starting": "0.25-0.5mg daily",
        "maintenance": "0.5-2mg daily",
        "maximum": "5mg daily in elderly",
        "renalAdjustment": "No adjustment needed",
        "hepaticAdjustment": "Use with extreme caution"
      },
      "contraindications": [
        "Parkinson's disease",
        "Lewy body dementia", 
        "Severe CNS depression",
        "Coma"
      ],
      "warnings": [
        "BLACK BOX WARNING: Increased mortality in dementia",
        "High risk of extrapyramidal symptoms",
        "QT prolongation risk",
        "Neuroleptic malignant syndrome"
      ],
      "sideEffects": {
        "common": ["Sedation", "Extrapyramidal symptoms", "Tardive dyskinesia", "Orthostatic hypotension"],
        "serious": ["Neuroleptic malignant syndrome", "QT prolongation", "Sudden death", "Stroke"]
      },
      "interactions": [
        {
          "drug": "QT-prolonging drugs",
          "severity": "Major",
          "description": "Additive QT prolongation risk"
        },
        {
          "drug": "Anticholinergics",
          "severity": "Major",
          "description": "Increased anticholinergic effects"
        }
      ],
      "monitoring": [
        "ECG (QT interval)",
        "Extrapyramidal symptoms (AIMS)",
        "Blood pressure",
        "Metabolic parameters",
        "Mental status"
      ],
      "beersCategory": "AVOID in dementia unless safer alternatives failed",
      "renalDosing": "No adjustment",
      "geriatricConsiderations": [
        "Use lowest effective dose for shortest duration",
        "High risk of falls and fractures",
        "Monitor closely for EPS",
        "Consider atypical antipsychotics first",
        "Non-pharmacological interventions preferred"
      ],
      "cost": "$ (inexpensive)",
      "availability": "Tablet, Solution, Injection"
    },
    {
      "id": "med-004", 
      "name": "Quetiapine",
      "genericName": "Quetiapine Fumarate",
      "brandNames": ["Seroquel", "Seroquel XR"],
      "category": "Antipsychotic",
      "class": "Atypical Antipsychotic",
      "indication": "Behavioral symptoms in dementia (off-label)",
      "dosing": {
        "starting": "12.5-25mg daily at bedtime",
        "maintenance": "25-100mg daily",
        "maximum": "300mg daily in elderly",
        "renalAdjustment": "No adjustment needed",
        "hepaticAdjustment": "Reduce dose in hepatic impairment"
      },
      "contraindications": [
        "Known hypersensitivity",
        "Coma",
        "Severe CNS depression"
      ],
      "warnings": [
        "BLACK BOX WARNING: Increased mortality in dementia",
        "Metabolic syndrome risk",
        "Orthostatic hypotension",
        "Falls risk"
      ],
      "sideEffects": {
        "common": ["Sedation", "Dizziness", "Dry mouth", "Weight gain", "Constipation"],
        "serious": ["Hyperglycemia", "Hyperlipidemia", "QT prolongation", "Tardive dyskinesia"]
      },
      "interactions": [
        {
          "drug": "CYP3A4 inhibitors",
          "severity": "Major",
          "description": "Increased quetiapine levels"
        },
        {
          "drug": "CNS depressants",
          "severity": "Moderate",
          "description": "Additive sedation"
        }
      ],
      "monitoring": [
        "Metabolic parameters (glucose, lipids, weight)",
        "Blood pressure",
        "ECG if risk factors",
        "Movement disorders",
        "Sedation level"
      ],
      "beersCategory": "AVOID in dementia unless safer alternatives failed",
      "renalDosing": "No adjustment",
      "geriatricConsiderations": [
        "Lower starting doses essential",
        "Monitor for metabolic effects",
        "High fall risk due to sedation",
        "Preferred over typical antipsychotics",
        "Regular reassessment for continued need"
      ],
      "cost": "$$$ (expensive for brand)",
      "availability": "Tablet, XR tablet"
    },
    {
      "id": "med-005",
      "name": "Diphenhydramine",
      "genericName": "Diphenhydramine Hydrochloride", 
      "brandNames": ["Benadryl", "Unisom"],
      "category": "Antihistamine",
      "class": "First-generation Antihistamine",
      "indication": "Allergic reactions, sleep aid",
      "dosing": {
        "starting": "12.5-25mg",
        "maintenance": "25-50mg every 6-8 hours",
        "maximum": "300mg daily",
        "renalAdjustment": "Extend dosing interval",
        "hepaticAdjustment": "Use with caution"
      },
      "contraindications": [
        "Narrow-angle glaucoma",
        "BPH with urinary retention",
        "Severe asthma or COPD"
      ],
      "warnings": [
        "Strong anticholinergic effects",
        "High risk of delirium in elderly",
        "Paradoxical excitement possible",
        "Photosensitivity"
      ],
      "sideEffects": {
        "common": ["Sedation", "Dry mouth", "Constipation", "Blurred vision", "Urinary retention"],
        "serious": ["Delirium", "Falls", "Cardiac arrhythmias", "Seizures"]
      },
      "interactions": [
        {
          "drug": "Other anticholinergics",
          "severity": "Major",
          "description": "Additive anticholinergic effects"
        },
        {
          "drug": "CNS depressants",
          "severity": "Moderate", 
          "description": "Increased sedation"
        }
      ],
      "monitoring": [
        "Mental status",
        "Urinary retention",
        "Constipation",
        "Fall risk",
        "Dry mouth/eyes"
      ],
      "beersCategory": "AVOID - Highly anticholinergic",
      "renalDosing": "Extend interval to every 12-18 hours if CrCl <50",
      "geriatricConsiderations": [
        "AVOID in elderly patients",
        "High risk of cognitive impairment",
        "Increases fall risk significantly",
        "Use safer alternatives for sleep/allergies",
        "If must use, lowest dose for shortest duration"
      ],
      "cost": "$ (inexpensive)",
      "availability": "Tablet, Capsule, Liquid, Topical"
    },
    {
      "id": "med-006",
      "name": "Lorazepam",
      "genericName": "Lorazepam",
      "brandNames": ["Ativan"],
      "category": "Benzodiazepine",
      "class": "Anxiolytic",
      "indication": "Anxiety, alcohol withdrawal, status epilepticus",
      "dosing": {
        "starting": "0.25-0.5mg BID-TID",
        "maintenance": "0.5-2mg daily divided",
        "maximum": "6mg daily (lower in elderly)",
        "renalAdjustment": "No adjustment needed",
        "hepaticAdjustment": "Reduce dose"
      },
      "contraindications": [
        "Acute narrow-angle glaucoma",
        "Severe respiratory insufficiency",
        "Sleep apnea syndrome"
      ],
      "warnings": [
        "Physical dependence and withdrawal",
        "Increased fall risk",
        "Cognitive impairment",
        "Respiratory depression with other CNS depressants"
      ],
      "sideEffects": {
        "common": ["Sedation", "Dizziness", "Weakness", "Unsteadiness", "Memory impairment"],
        "serious": ["Falls", "Fractures", "Respiratory depression", "Delirium", "Dependence"]
      },
      "interactions": [
        {
          "drug": "Opioids",
          "severity": "Major", 
          "description": "Increased risk of respiratory depression"
        },
        {
          "drug": "Alcohol",
          "severity": "Major",
          "description": "Additive CNS depression"
        }
      ],
      "monitoring": [
        "Sedation level",
        "Fall risk",
        "Cognitive function",
        "Signs of dependence",
        "Respiratory status"
      ],
      "beersCategory": "AVOID - High risk of cognitive impairment and falls",
      "renalDosing": "No adjustment (not renally eliminated)",
      "geriatricConsiderations": [
        "AVOID in elderly if possible",
        "If used, lowest dose for shortest duration",
        "Taper slowly to prevent withdrawal",
        "High risk of falls and cognitive decline",
        "Consider non-pharmacologic alternatives"
      ],
      "cost": "$ (inexpensive)",
      "availability": "Tablet, Solution, Injection"
    },
    {
      "id": "med-007",
      "name": "Tramadol",
      "genericName": "Tramadol Hydrochloride",
      "brandNames": ["Ultram", "ConZip"],
      "category": "Opioid",
      "class": "Atypical Opioid",
      "indication": "Moderate pain",
      "dosing": {
        "starting": "25mg daily (elderly)",
        "maintenance": "50-100mg every 6 hours",
        "maximum": "300mg daily in elderly",
        "renalAdjustment": "Extend interval if CrCl <30",
        "hepaticAdjustment": "Reduce dose in severe impairment"
      },
      "contraindications": [
        "Significant respiratory depression",
        "Acute or severe bronchial asthma",
        "Known or suspected GI obstruction"
      ],
      "warnings": [
        "Seizure risk",
        "Serotonin syndrome",
        "Respiratory depression",
        "Falls risk in elderly"
      ],
      "sideEffects": {
        "common": ["Nausea", "Dizziness", "Constipation", "Headache", "Sedation"],
        "serious": ["Seizures", "Serotonin syndrome", "Respiratory depression", "Falls"]
      },
      "interactions": [
        {
          "drug": "SSRIs/SNRIs",
          "severity": "Major",
          "description": "Increased serotonin syndrome risk"
        },
        {
          "drug": "MAOIs",
          "severity": "Major",
          "description": "Serotonin syndrome risk"
        }
      ],
      "monitoring": [
        "Pain relief",
        "Respiratory status", 
        "Neurological symptoms",
        "Bowel function",
        "Falls assessment"
      ],
      "beersCategory": "Use with CAUTION - Increased risk of falls",
      "renalDosing": "Extend to every 12 hours if CrCl <30",
      "geriatricConsiderations": [
        "Start with lower doses",
        "High fall risk due to dizziness",
        "Monitor for serotonin syndrome",
        "Consider acetaminophen first",
        "Avoid in patients on antidepressants if possible"
      ],
      "cost": "$$ (moderate)",
      "availability": "Tablet, ER tablet"
    },
    {
      "id": "med-008",
      "name": "Hydrochlorothiazide",
      "genericName": "Hydrochlorothiazide",
      "brandNames": ["Microzide"],
      "category": "Diuretic",
      "class": "Thiazide Diuretic",
      "indication": "Hypertension, edema",
      "dosing": {
        "starting": "12.5-25mg daily",
        "maintenance": "12.5-50mg daily",
        "maximum": "50mg daily",
        "renalAdjustment": "Ineffective if CrCl <30",
        "hepaticAdjustment": "Use with caution"
      },
      "contraindications": [
        "Anuria",
        "Hypersensitivity to thiazides",
        "Severe renal impairment"
      ],
      "warnings": [
        "Electrolyte imbalances",
        "Hyperuricemia",
        "Hyperglycemia",
        "Photosensitivity"
      ],
      "sideEffects": {
        "common": ["Hyponatremia", "Hypokalemia", "Hyperuricemia", "Dizziness", "Headache"],
        "serious": ["Severe electrolyte abnormalities", "Acute angle-closure glaucoma", "Acute pancreatitis"]
      },
      "interactions": [
        {
          "drug": "ACE inhibitors",
          "severity": "Moderate",
          "description": "Additive hypotension, hyperkalemia risk with ACEi"
        },
        {
          "drug": "NSAIDs",
          "severity": "Moderate",
          "description": "Reduced antihypertensive effect"
        }
      ],
      "monitoring": [
        "Electrolytes (Na, K, Mg)",
        "Renal function",
        "Blood pressure",
        "Glucose",
        "Uric acid"
      ],
      "beersCategory": "Not listed",
      "renalDosing": "Avoid if CrCl <30 mL/min",
      "geriatricConsiderations": [
        "Monitor electrolytes closely",
        "Start with 12.5mg daily",
        "High risk of hyponatremia",
        "May worsen incontinence",
        "Monitor for orthostatic hypotension"
      ],
      "cost": "$ (inexpensive)",
      "availability": "Tablet, Capsule"
    },
    {
      "id": "med-009",
      "name": "Omeprazole", 
      "genericName": "Omeprazole",
      "brandNames": ["Prilosec"],
      "category": "Proton Pump Inhibitor",
      "class": "PPI",
      "indication": "GERD, peptic ulcer disease",
      "dosing": {
        "starting": "20mg daily",
        "maintenance": "20-40mg daily",
        "maximum": "80mg daily",
        "renalAdjustment": "No adjustment needed",
        "hepaticAdjustment": "Reduce dose in severe impairment"
      },
      "contraindications": [
        "Hypersensitivity to omeprazole",
        "Concurrent use with rilpivirine"
      ],
      "warnings": [
        "Increased infection risk (C. diff)",
        "Bone fracture risk",
        "Hypomagnesemia with long-term use",
        "Vitamin B12 deficiency"
      ],
      "sideEffects": {
        "common": ["Headache", "Nausea", "Diarrhea", "Abdominal pain", "Constipation"],
        "serious": ["C. diff infection", "Hip fractures", "Severe hypomagnesemia", "Acute interstitial nephritis"]
      },
      "interactions": [
        {
          "drug": "Clopidogrel",
          "severity": "Major",
          "description": "Reduced antiplatelet effect"
        },
        {
          "drug": "Warfarin",
          "severity": "Moderate",
          "description": "Increased warfarin levels"
        }
      ],
      "monitoring": [
        "Symptom improvement",
        "Magnesium levels (long-term)",
        "Vitamin B12 (long-term)",
        "Bone density (long-term)"
      ],
      "beersCategory": "Use with CAUTION - Long-term use >8 weeks",
      "renalDosing": "No adjustment",
      "geriatricConsiderations": [
        "Use lowest effective dose",
        "Limit duration when possible",
        "Monitor for drug interactions",
        "Consider H2 blocker alternatives",
        "Assess continued need regularly"
      ],
      "cost": "$ (inexpensive generic)",
      "availability": "Capsule, Tablet"
    },
    {
      "id": "med-010",
      "name": "Metformin",
      "genericName": "Metformin Hydrochloride", 
      "brandNames": ["Glucophage", "Fortamet"],
      "category": "Antidiabetic",
      "class": "Biguanide",
      "indication": "Type 2 diabetes mellitus",
      "dosing": {
        "starting": "500mg daily or BID with meals",
        "maintenance": "1000-2000mg daily divided",
        "maximum": "2550mg daily",
        "renalAdjustment": "Contraindicated if eGFR <30",
        "hepaticAdjustment": "Avoid in severe impairment"
      },
      "contraindications": [
        "eGFR <30 mL/min/1.73m²",
        "Metabolic acidosis",
        "Diabetic ketoacidosis",
        "Severe heart failure"
      ],
      "warnings": [
        "Lactic acidosis (rare but serious)",
        "Vitamin B12 deficiency",
        "Hold before contrast procedures",
        "GI intolerance common initially"
      ],
      "sideEffects": {
        "common": ["Nausea", "Diarrhea", "Abdominal discomfort", "Metallic taste", "Loss of appetite"],
        "serious": ["Lactic acidosis", "Severe hypoglycemia (with other agents)"]
      },
      "interactions": [
        {
          "drug": "Contrast agents",
          "severity": "Major", 
          "description": "Hold metformin to prevent lactic acidosis"
        },
        {
          "drug": "Alcohol",
          "severity": "Moderate",
          "description": "Increased lactic acidosis risk"
        }
      ],
      "monitoring": [
        "HbA1c",
        "Renal function (eGFR)",
        "Vitamin B12 levels",
        "Lactate if clinically indicated"
      ],
      "beersCategory": "Not listed",
      "renalDosing": "Avoid if eGFR <30; reduce dose if eGFR 30-45",
      "geriatricConsiderations": [
        "Monitor renal function closely",
        "Start with lower doses",
        "Hold during acute illness",
        "First-line diabetes medication",
        "Assess eGFR every 3-6 months"
      ],
      "cost": "$ (inexpensive)",
      "availability": "Tablet, ER tablet, Solution"
    }
  ],
  "drugInteractionChecker": {
    "majorInteractions": [
      {
        "drug1": "Warfarin",
        "drug2": "Omeprazole", 
        "severity": "Major",
        "mechanism": "CYP2C19 inhibition increases warfarin levels",
        "management": "Monitor INR closely, consider dose reduction",
        "clinicalSignificance": "Increased bleeding risk"
      },
      {
        "drug1": "Tramadol",
        "drug2": "Sertraline",
        "severity": "Major",
        "mechanism": "Both increase serotonin levels",
        "management": "Avoid combination or monitor closely for serotonin syndrome",
        "clinicalSignificance": "Serotonin syndrome risk"
      }
    ]
  },
  "beersCategories": [
    {
      "category": "AVOID",
      "description": "These medications should generally be avoided in adults ≥65 years",
      "examples": ["Diphenhydramine", "Lorazepam", "Haloperidol (for dementia)"]
    },
    {
      "category": "USE WITH CAUTION",
      "description": "Use with caution due to increased risk in older adults",
      "examples": ["Tramadol", "Omeprazole (>8 weeks)"]
    }
  ],
  "geriatricPrinciples": [
    "Start low, go slow",
    "Consider non-pharmacological alternatives first",
    "Regular medication reviews and deprescribing",
    "Monitor for adverse drug events closely",
    "Consider drug-drug interactions",
    "Adjust for renal and hepatic function",
    "Consider goals of care and life expectancy"
  ]
}